Scripps Whittier Institute for Diabetes’ leading role in the global effort to develop long-acting insulin was on full display recently when the institute’s corporate vice president, Athena Philis-Tsimikas, MD, presented encouraging clinical trial results at a major medical conference in Stockholm.
Dr. Philis-Tsimikas was a lead investigator in the study that compared an experimental weekly insulin shot to the more typical one-a-day insulin shot in patients with type 2 diabetes.
Watch the 10News report: Scripps Health Study Could Drasticaally Cut Insulin Shots From Once a Day to Once a Week
Read the San Diego Union-Tribune article: Once-Per-Week Insulin Shots? New Research by Scripps Doctor Showing Promise
Read the BioSpace article: Novo’s Once-Weekly Insulin Treatment Part of a Transforming T2D Space